IMG Oncologists
@IMG_Oncologists
Followers
2K
Following
2K
Statuses
2K
@ASCO volunteer-led International Medical Graduates Community of Practice #IMGOncCoP. Views, opinions, and content not endorsed, supported or moderated by ASCO.
United States
Joined July 2022
🥁Excited to invite you to join @ASCO #IMGoncCoP! Connect, mentor, and support #IMGs through initiatives on visas, mentorship, community practice, leadership, and more. 🙏We’re looking for members and leads. Please fill our survey with your interest!! 👉
4
29
68
RT @SakditadMD: So excited to join #GU25 #ASCO @ASCO and present my poster! 🌟 Building connections and big things together with world-ren…
0
0
0
RT @MamthaB: Nice overview of the HLH and its criteria to remember👇👇 @IMG_Oncologists @oncodaily @HemOncFellows
0
1
0
RT @ReneeSaliby: Less than a week until #GU25 Super excited to reunite with friends and colleagues and learn about the latest updates in…
0
7
0
RT @SakditadMD: 🕺🏽🧠 Fantastic insights from #SABCS24 @SABCSSanAntonio on crucial breast cancer trials! Thanks to @NrajShah and @Charmi_Bh…
0
2
0
RT @yekeduz_emre: 📣A new era has just started in the treatment of kidney cancer! 🎯This masterpiece study put novel insights on RCC treatme…
0
4
0
RT @SakditadMD: New study from @JCOOP_ASCO reveals a significant decrease in burnout among oncology fellows over the last decade! From 34%…
0
5
0
RT @DrChoueiri: 6/ At a median follow-up of 40.2 mths from nephrectomy, none of the 9 vaccinated patients experienced a recurrence of their…
0
3
0
RT @DrChoueiri: 5/ This phase trial involved 9 patients with stage III or IV RCC, who received a neoantigen-targeting PCV +/- subcutaneous…
0
4
0
RT @DrChoueiri: 4/ The Personalized Cancer Vaccine (PCV) is based on the sequencing of the patient’s tumors to identify personal neoantigen…
0
5
0
RT @DrChoueiri: 3/ Unlike melanoma, RCC has a lower mutation burden. While adjuvant pembrolizumab improved DFS and OS of patients with RCC,…
0
6
0
RT @DrChoueiri: 2/ This work builds on the foundation established by the first personal neoantigen vaccine for melanoma (high tumor burden…
0
8
0
RT @DrChoueiri: 1/ JUST IN: an 8 year #kidneycancer journey now published in @Nature: “A personalized neoantigen vaccine generates anti-tum…
0
203
0
RT @jamecancerdoc: #WorldCancerDay @JournalCancer @OncoAlert in aggregate GI cancers are major causes of mortality…
0
17
0
RT @MamthaB: Thank you, @Mohty_EBMT, for sharing this information! Being in training and paying submission fees can be challenging for trai…
0
2
0
RT @DRBakaloudiMD: 🎧Is there a better way to support @ConquerCancerFd on the #WorldCancerDay than listening to music?? 🎶 See below for th…
0
2
0
RT @StephenVLiu: Report from @ASCO on US oncologist well-being show 59% of oncologists report burnout and 75% of them plan on decreasing cl…
0
52
0
RT @montypal: I would love to get some more poster submissions from our talented Southern California trainees! Please consider submitting y…
0
17
0
RT @ReginaBarCar: 🧐 Did you miss any key studies in 2024? Don't worry, the #OncoAlert Colloquium has EVERYTHING covered! 🏆 🎯 An excellent r…
0
9
0
RT @DrDanielHeng: Treatment free survival is becoming an important endpoint when looking at different #mRCC treatments. VEGF alone had sh…
0
50
0
RT @DrChoueiri: Bravo @DanaFarber GU Post-docs! Thank you @ASCO ! @DanaFarber_GU @ConquerCancerFd #GU25
0
6
0